Clinical variables identify seronegative HCV co-infection in HIV-infected individuals

Journal of Clinical Virology

Volumn 52, Issue 4, 2011, Pages 328-332

  Bharti, Ajay R ^a   Letendre, Scott L ^a   Wolfson, Tanya ^a   Clifford, David ^b   Collier, Ann C ^c   Gelman, Benjamin ^d   McArthur, Justin ^e   Marra, Christina ^c   McCutchan, Allen ^a   Morgello, Susan ^f   Simpson, David ^f   Ellis, Ron J ^a   Grant, Igor ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Case finding; Co infection; HIV; Seronegative HCV

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL FEATURE; CLINICAL TRIAL; DATA ANALYSIS; ETHNICITY; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIXED INFECTION; PRIORITY JOURNAL; SERODIAGNOSIS; THROMBOCYTE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; COINFECTION; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; RNA, VIRAL; SUBSTANCE ABUSE, INTRAVENOUS; THROMBOCYTOPENIA;

EID: 82755160756     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.08.021     Document Type: Article

References (22)

1. Alter M.J., Kruszon-Moran D., Nainan O.V., et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999, 341(August 19 (8)):556-562.
2. Brau N., Bini E.J., Shahidi A., et al. Prevalence of hepatitis C and coinfection with HIV among United States veterans in the New York City metropolitan area. Am J Gastroenterol 2002, 97(August (8)):2071-2078.
3. Sherman K.E., Rouster S.D., Chung R.T., Rajicic N. Hepatitis C Virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis 2002, 34(March 15 (6)):831-837.
4. Turner J., Bansi L., Gilson R., et al. The prevalence of hepatitis C virus (HCV) infection in HIV-positive individuals in the UK - trends in HCV testing and the impact of HCV on HIV treatment outcomes. J Viral Hepat 2010, 17(August (1)):569-577.
5. Thomas D.L., Shih J.W., Alter H.J., et al. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis 1996, 174(October (4)):690-695.
6. Benhamou Y., Bochet M., Di Martino V., et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The multivirc group. Hepatology 1999, 30(October (4)):1054-1058.
7. Soto B., Sanchez-Quijano A., Rodrigo L., et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997, 26(January (1)):1-5.
8. Backus L.I., Phillips B.R., Boothroyd D.B., et al. Effects of hepatitis C virus coinfection on survival in veterans with HIV treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2005, 39(August 15 (5)):613-619.
9. Sabin C.A., Telfer P., Phillips A.N., Bhagani S., Lee C.A. The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men. J Infect Dis 1997, 175(January (1)):164-168.
10. Seminari E., Tinelli C., Ravasi G., et al. Hepatitis C infection on immune recovery in HIV-positive patients on successful HAART: the role of genotype 3. Curr HIV Res 2010, 8(April 1 (3)):186-193.
11. Fuping G., Wei L., Yang H., et al. Impact of Hepatitis C Virus coinfection on HAART in HIV-infected individuals: multicentric observation cohort. J Acquir Immune Defic Syndr 2010, 54(April 26 (2)):137-142.
12. Grebely J., Raffa J.D., Lai C., et al. Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents. J Viral Hepat 2011, 18(January (1)):32-41.
13. USPHS/IDSA 2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. HIV Clin Trials 2001, 2(November-December (6)):493-554.
14. Chamie G., Bonacini M., Bangsberg D.R., et al. Factors associated with seronegative chronic hepatitis C virus infection in HIV infection. Clin Infect Dis 2007, 44(February 15 (4)):577-583.
15. Bonacini M., Lin H.J., Hollinger F.B. Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus. J Acquir Immune defic Syndr 2001, 26(April 1 (4)):340-344.
16. Hall C.S., Charlebois E.D., Hahn J.A., Moss A.R., Bangsberg D.R. Hepatitis C virus infection in San Francisco's HIV-infected urban poor. J Gen Intern Med 2004, 19(April (4)):357-365.
17. George S.L., Gebhardt J., Klinzman D., et al. Hepatitis C virus viremia in HIV-infected individuals with negative HCV antibody tests. J Acquir Immune Defic Syndr 2002 Oct 1, 31(2):154-162.
18. Pratt D.S., Kaplan M.M. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 2000, 342(April 27 (17)):1266-1271.
19. Streiff M.B., Mehta S., Thomas D.L. Peripheral blood count abnormalities among patients with hepatitis C in the United States. Hepatology 2002, 35(April (4)):947-952.
20. Bartolome J., Lopez-Alcorocho J.M., Castillo I., et al. Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C. J Virol 2007, 81(July (14)):7710-7715.
21. Castillo I., Pardo M., Bartolome J., et al. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 2004, 189(January 1 (1)):7-14.
22. Thomson E.C., Nastouli E., Main J., et al. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS (London, England) 2009, 23(January 2 (1)):89-93.